Related references
Note: Only part of the references are listed.Serine peptidase inhibitor Kazal type III (SPINK3) promotes BRL-3A cell proliferation by targeting the PI3K-AKT signaling pathway
Cuifang Chang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
Ritika Tiwari et al.
NATURE COMMUNICATIONS (2020)
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
Nastassja Terraneo et al.
CANCERS (2020)
Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma
Christine Mehner et al.
ONCOGENE (2020)
SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
Ti-Chun Chan et al.
THERANOSTICS (2020)
L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer
Karuna Ganesh et al.
NATURE CANCER (2020)
The Extracellular Matrix Modulates the Metastatic Journey
FuiBoon Kai et al.
DEVELOPMENTAL CELL (2019)
Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo
Ling Wei et al.
PHARMACOLOGICAL RESEARCH (2019)
Association and diagnostic value of serum SPINK4 in colorectal cancer
Mingzhi Xie et al.
PEERJ (2019)
Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
Rong-Yaun Shyu et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Downregulated SPINK4 is associated with poor survival in colorectal cancer
Xiaojie Wang et al.
BMC CANCER (2019)
Colorectal Cancer: Why Does Side Matter?
Claire Gallois et al.
DRUGS (2018)
The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses
Nurit P. Azouz et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Joo Sang Lee et al.
CELL (2018)
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
Naveed Ishaque et al.
NATURE COMMUNICATIONS (2018)
SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker
Liyun Xu et al.
BMB REPORTS (2018)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Rectal Cancer in Asian vs. Western Countries: Why the Variation in Incidence?
Yanhong Deng
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Xian Zhang et al.
MOLECULAR CELL (2016)
Serine protease HtrA1 as an inhibitor on proliferation invasion and migration of gastric cancer
Zhiguo Zhao et al.
MEDICAL ONCOLOGY (2015)
SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression
R. Tiwari et al.
ONCOGENESIS (2015)
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Manuel Valiente et al.
CELL (2014)
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
Jean-Francois Bosset et al.
LANCET ONCOLOGY (2014)
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
Laura De Caluwe et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis
Felix Lu et al.
IMMUNOLOGY (2011)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Serine Protease Inhibitor Kazal Type 1 Promotes Proliferation of Pancreatic Cancer Cells through the Epidermal Growth Factor Receptor
Nobuyuki Ozaki et al.
MOLECULAR CANCER RESEARCH (2009)
Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer
A. S. Caudle et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis
Xuanyong Lu et al.
APOPTOSIS (2008)
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity
Jeremy Chien et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The role of genetics in the development of asthma and atopy
MN Blumenthal
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Hyperinsulinemia and risk of Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2004)
Gene expression patterns associated with infertility in humans and rodent models
JC Rockett et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
Identification of the bioactive peptide PEC-60 in brain
Å Norberg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells
A Baldi et al.
ONCOGENE (2002)